Search Results 521-530 of 12540 for alp

  1. Clinical Trials - The SHUNT-V Study for Varices

    Participation eligibility · Abnormal liver enzymes (AST, ALT, or alkaline phosphatase), or, abnormal direct bilirubin, albumin, or INR (liver-related) of greater ...

  2. radiotherapy Archives - Mayo Clinic News Network

  3. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    alkaline phosphatase > 2.5 times upper normal limit (unless due to chronic GVHD); Pregnant or lactating women. Women of childbearing potential must have a ...

  4. A Study to Evaluate the Effectiveness and Safety of Pamrevlumab in Patients with Idiopathic Pulmonary Fibrosis - Mayo Clinic

    ... alkaline phosphatase ≥ 2 x ULN. Ongoing acute IPF exacerbation, or suspicion of such process during screening or randomization, including hospitalization ...

  5. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Latiglutenase to Treat Patients with Well-Controlled Celiac Disease - Mayo Clinic

    Participation eligibility · Elevated liver function tests (Alanine Aminotransferase [ALT], Aspartate Transaminase[AST],Alkaline Phosphatase [Alk Phos], or Gamma- ...

  6. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism - Mayo Clinic

    Increased risk for osteosarcoma, such as those with Paget''s disease of bone or unexplained elevations of alkaline phosphatase, open epiphyses, hereditary ...

  7. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Alkaline phosphatase ≤ 3 times ULN (≤ 5 times ULN if evidence of direct liver involvement by lymphoma); AST ≤ 3 times ULN (≤ 5 times ULN if evidence of ...

  8. A Study to Evaluate Setmelanoitide to Treat Patients with Rare Genetic Disorders of Obesity - Mayo Clinic

    ... alkaline phosphatase, or serum bilirubin). Note: Patients entering the study with SRC1 haploinsufficiency obesity must be evaluated during the Screening ...

  9. Dr. William Young Archives - Mayo Clinic News Network

  10. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

    Alkaline phosphatase ≤ 2.5 times ULN; Creatinine normal OR creatinine clearance ≥ 60 mL/min; LVEF ≥ 50% by MUGA scan or echocardiogram; Able to complete ...